Latest posts
-
BioStem Technologies: CMS Decision a “Win For Patients”
POMPANO BEACH, FLORIDA, September 29, 2023 – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, today hails a decision by the Centers for Medicare & Medicaid Services (CMS) as being in the best interests of patients. Three Medicare
-
Neon Bloom Signs Letter of Intent to Acquire Advanced Executive Sales, LLC
Acquisition Expected to Initially Increase Annual Revenues by $20 Million this Year COLUMBIA, MD, September 28, 2023 – Neon Bloom, Inc. (OTC PINK: NBCO), announced today that it has signed a Letter of Intent to acquire Advanced Executive Sales, LLC (AES), a leading financial services company specializing in generating transactional revenue for many types of
-
“We have already demonstrated scientifically that our process and product is exceptional.” Jason Matuszewski, Chief Executive Officer September 26, 2023 BioStem Technologies (OTC: BSEM) has received Investigational Review Board (IRB) approval for a clinical study that will investigate the utilization and effects of its Vendaje Ⓡ wound care product in diabetic foot ulcers. “We have
-
AURI signs The Champ, and launches new products line
DALLAS, TX, September 27, 2023 – Auri Inc. (OTC PINK: AURI) (“AURI”) (the “Company”) is proud to announce today the signing of Heavyweight World Champion, Riddick Bowe. Auri Inc. is launching “The Champ” line of consumable products featuring CBD and THC Delta 9 infused Gummies, Energy Drinks, Vitamin Water and a host of other Nutraceutical products. These
-
StemSation International Announces Acquisition Plans
StemSation International is providing updates on corporate planning and direction for potential new acquisitions in the green energy space Plantation, Florida, September 27, 2023 – StemSation International (OTC: STSN), a South-Florida based company that has licensed technology for the production and distribution of flavored, canned oxygen products is announcing strategic acquisition planning for the upcoming
-
BioStem Technologies Takes on Diabetic Foot Ulcers with Innovative Wound Care Product
“We have already demonstrated scientifically that our process and product is exceptional.” Jason Matuszewski, Chief Executive Officer September 26, 2023 BioStem Technologies (OTC: BSEM) has received Investigational Review Board (IRB) approval for a clinical study that will investigate the utilization and effects of its Vendaje Ⓡ wound care product in diabetic foot ulcers. “We have already
-
BioStem Receives IRB Approval for Clinical Study to Evaluate Vendaje® in Diabetic Foot Ulcers
POMPANO BEACH, FLORIDA, September 26, 2023 – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, announced today the approval of an Investigational Review Board (IRB) sanctioned clinical study. This study aims to investigate the utilization and effects of
-
TransGlobal Assets Inc. (OTC: TMSH) Wholly Owned Subsidiary, Better Health Sciences Inc., Acquires the Assets of Synergy Health Services Inc.
Ann Arbor, Michigan, September 26, 2023 – TransGlobal Assets Inc. (OTC: TMSH) is pleased to announce that, pursuant to an Acquisition Agreement, its wholly owned subsidiary Better Health Sciences, Inc., has acquired 100% of the assets of Synergy Health Services Inc. Synergy Health Services Inc., is a multidisciplinary Wellness Centre that provides evidence-based natural health
-
RIGHT ON BRANDS – CORPORATE UPDATE
DALLAS, TX, September 26, 2023 – Right on Brands, Inc. (OTC PINK: (RTOND), a fully reporting SEC filer and developer of a broad line of hemp-based and THC products, announces that the reverse is now effective. We are excited with the new corporate restructure, which will now enable the company to raise significant capital to
-
RemSleep Holdings Inc. Provides an Update on Funding and DeltaWave
Tampa, FL, September 25, 2023 – RemSleep Holdings Inc. (OTCQB: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to Obstructive Sleep Apnea (OSA) patients, announces a new investor agreement and DeltaWave submission update. RemSleep recently entered into a Purchase Agreement with Janbella Group, LLC which was the subject of